Description
Manufacturer:
Intas Pharmaceuticals Ltd
Salt Composition:
Desvenlafaxine (100mg)
Description:
Ventab DXT 100mg Cap contains doxofylline, a methylxanthine derivative used as a bronchodilator in the management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).
Doxofylline works by relaxing the smooth muscles in the airways, making breathing easier. Unlike the older methylxanthine, theophylline, doxofylline is often reported to have a potentially better safety profile with fewer cardiovascular and central nervous system side effects, although this can vary between individuals.
It is believed to act through several mechanisms, including inhibiting phosphodiesterase enzymes (which leads to bronchodilation), antagonizing platelet-activating factor (PAF), and potentially having some anti-inflammatory effects and improving mucociliary clearance.
Ventab DXT is prescribed to help relieve symptoms of asthma and COPD, such as wheezing, shortness of breath, and chest tightness. The 100mg capsule strength allows for flexible dosing based on the patient’s needs and response, as determined by a healthcare professional. The usual dosage of doxofylline varies depending on the individual and the severity of their condition.
Reviews
There are no reviews yet.